Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
EDIT

Editas Medicine

$30.34

-0.6 (-1.94%)

18:02
12/09/19
12/09
18:02
12/09/19
18:02
Hot Stocks
Editas Medicine announces in vivo proof-of-concept data for EDIT-301 »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
BOLD

Audentes Therapeutics

$28.59

-0.41 (-1.41%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

07:34
12/03/19
12/03
07:34
12/03/19
07:34
Downgrade
Audentes Therapeutics, Astellas Pharma, Editas Medicine, Intellia Therapeutics, Crispr Therapeutics rating change at Raymond James »

Audentes downgraded to…

BOLD

Audentes Therapeutics

$28.59

-0.41 (-1.41%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

EDIT

Editas Medicine

$29.90

-0.32 (-1.06%)

NTLA

Intellia Therapeutics

$17.05

-0.21 (-1.22%)

CRSP

Crispr Therapeutics

$68.60

-3.07 (-4.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 03

    Dec

  • 07

    Dec

Over a month ago
EDIT

Editas Medicine

$20.38

-0.17 (-0.83%)

08:19
11/12/19
11/12
08:19
11/12/19
08:19
Earnings
Editas Medicine reports Q3 EPS (66c) vs. (32c) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

EDIT

Editas Medicine

$20.38

-0.17 (-0.83%)

, CELG

Bought by BMY

$109.56

0.06 (0.05%)

07:29
11/12/19
11/12
07:29
11/12/19
07:29
Hot Stocks
Editas Medicine, Celgene amend collaboration for T Cell medicines »

Editas Medicine, Inc.…

EDIT

Editas Medicine

$20.38

-0.17 (-0.83%)

CELG

Bought by BMY

$109.56

0.06 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 04

    Dec

  • 07

    Dec

  • 25

    Mar

  • 04

    Apr

EDIT

Editas Medicine

$21.63

0.66 (3.15%)

18:56
10/28/19
10/28
18:56
10/28/19
18:56
Hot Stocks
Editas Medicine names Judith Abrams, M.D. as Chief Medical Officer »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDIT

Editas Medicine

$20.30

0.48 (2.42%)

18:15
10/15/19
10/15
18:15
10/15/19
18:15
Hot Stocks
Editas Medicine, AskBio enter research collaboration over in vivo delivery »

Editas Medicine and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABUS

Arbutus Biopharma

$0.90

-0.2 (-18.18%)

, CLLS

Cellectis

$10.35

0.115 (1.12%)

04:55
10/08/19
10/08
04:55
10/08/19
04:55
Conference/Events
Chardan to hold a conference »

3rd Annual Genetic…

ABUS

Arbutus Biopharma

$0.90

-0.2 (-18.18%)

CLLS

Cellectis

$10.35

0.115 (1.12%)

ISEE

IVERIC bio

$1.05

-0.035 (-3.23%)

SGMO

Sangamo

$8.57

0.04 (0.47%)

CLSN

Celsion

$1.74

-0.005 (-0.29%)

NTLA

Intellia Therapeutics

$11.97

-0.17 (-1.40%)

PTCT

PTC Therapeutics

$33.98

-1.21 (-3.44%)

RGNX

Regenxbio

$37.37

-1.16 (-3.01%)

GOLD

Barrick Gold

$17.64

-0.11 (-0.62%)

DRNA

Dicerna

$14.47

0.13 (0.91%)

EDIT

Editas Medicine

$21.33

-0.44 (-2.02%)

NBSE

NeuBase Therapeutics

$4.95

-0.26 (-4.99%)

PRQR

ProQR Therapeutics

$6.15

-0.03 (-0.49%)

SELB

Selecta Biosciences

$1.75

-0.02 (-1.13%)

RCKT

Rocket Pharmaceuticals

$11.77

0.12 (1.03%)

AGTC

Applied Genetic

$3.39

-0.16 (-4.51%)

MRNA

Moderna

$15.46

-0.06 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Oct

  • 08

    Oct

  • 11

    Oct

  • 11

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

ABUS

Arbutus Biopharma

$1.10

-0.33 (-23.08%)

, CLLS

Cellectis

$10.24

0.065 (0.64%)

08:18
10/07/19
10/07
08:18
10/07/19
08:18
Conference/Events
Chardan to hold a conference »

3rd Annual Genetic…

ABUS

Arbutus Biopharma

$1.10

-0.33 (-23.08%)

CLLS

Cellectis

$10.24

0.065 (0.64%)

ISEE

IVERIC bio

$1.09

-0.015 (-1.36%)

SGMO

Sangamo

$8.53

-0.09 (-1.04%)

CLSN

Celsion

$1.75

-0.005 (-0.29%)

NTLA

Intellia Therapeutics

$12.14

0.2 (1.68%)

PTCT

PTC Therapeutics

$35.19

1.28 (3.77%)

RGNX

Regenxbio

$38.53

0.51 (1.34%)

GOLD

Barrick Gold

$17.75

0.5 (2.90%)

DRNA

Dicerna

$14.34

0.08 (0.56%)

EDIT

Editas Medicine

$21.77

0.12 (0.55%)

NBSE

NeuBase Therapeutics

$5.21

-0.02 (-0.38%)

PRQR

ProQR Therapeutics

$6.18

0.18 (3.00%)

SELB

Selecta Biosciences

$1.77

(0.00%)

RCKT

Rocket Pharmaceuticals

$11.65

-0.4 (-3.32%)

AGTC

Applied Genetic

$3.55

-0.18 (-4.83%)

MRNA

Moderna

$15.52

0.45 (2.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Oct

  • 08

    Oct

  • 11

    Oct

  • 11

    Oct

  • 16

    Oct

  • 17

    Oct

EDIT

Editas Medicine

$21.77

0.12 (0.55%)

07:06
10/07/19
10/07
07:06
10/07/19
07:06
Hot Stocks
Editas Medicine, MaxCyte announce clinical, commercial license agreement »

Editas Medicine and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Oct

Over a quarter ago
MGNX

MacroGenics

$13.89

0.17 (1.24%)

, QURE

uniQure

$56.06

0.64 (1.15%)

04:55
09/05/19
09/05
04:55
09/05/19
04:55
Conference/Events
Citigroup to hold a conference »

14th Annual Biotech…

MGNX

MacroGenics

$13.89

0.17 (1.24%)

QURE

uniQure

$56.06

0.64 (1.15%)

RGNX

Regenxbio

$32.97

-0.34 (-1.02%)

TPTX

Turning Point Therapeutics

$48.27

-2.93 (-5.72%)

ZYME

Zymeworks

$27.10

1.1 (4.23%)

MLND

Millendo Therapeutics

$4.90

0.13 (2.73%)

BOLD

Audentes Therapeutics

$29.60

-0.35 (-1.17%)

CALA

Calithera Biosciences

$3.78

-0.135 (-3.45%)

DERM

Dermira

$7.63

-0.19 (-2.43%)

EDIT

Editas Medicine

$23.17

-0.71 (-2.97%)

PIRS

Pieris Pharmaceuticals

$4.99

0.15 (3.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

  • 05

    Sep

  • 09

    Sep

  • 09

    Sep

  • 11

    Sep

  • 24

    Sep

  • 27

    Sep

  • 06

    Sep

  • 06

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.